Guidelines for Management and Treatment of Dyslipidemia in Indonesia
Standard Treatment Guidelines
Human strongyloidiasis is a chronic parasitic disease caused by infection with Strongyloides stercoralis, a soil-transmitted helminth that is estimated to infect 300–600 million people worldwide. This neglected tropical disease (NTD) is endemic globally, predominately in the South-East Asia, Afric
...
an and Western Pacific regions, and in South and Central America. Strongyloidiasis has a wide range of clinical presentations, including subclinical disease, symptomatic disease (often with diarrhoea, abdominal pain and urticaria) and a rare but deadly complication of hyperinfection with disseminated disease. The feared complication of disseminated strongyloidiasis can occur in the setting of immunocompromising conditions (e.g. human T-cell lymphotropic virus type 1 infection and malignancies) or immunosuppressive medications (e.g. steroids) and has an estimated case-fatality rate exceeding 60%. The standard treatment for chronic S. stercoralis infection is oral medication with ivermectin.
more
Guidelines for Therapy and Management of Urothelial Urinary Bladder Cancer
Standard Treatment Guideline
Standard Treatment Guideline
Guidelines for the Management and Therapy of Urine Incontinence in Children in Indonesia
For the whole document see:
http://www.aidstar-one.com/sites/default/files/treatment/national_treatment_guidelines/Zimbabwe_2010_tagged.pdf
Therapeutic Guidelines for Using Implant Cardiovascular Electronic Device in Indonesia
Standard Treatment Guideline
Guidelines for Therapy and Management of Hypertension in Cardiovascular Disease in Indonesia
Guidelines for the Prevention of Cardiovascular Disease in Women in Indonesia
Diagnosing asthma in children represents an important clinical challenge. There is no single gold-standard test to confirm the diagnosis. Consequently, over- and under-diagnosis of asthma is frequent in children. A task force supported by the Europe
...
an Respiratory Society has developed these evidence-based clinical practice guidelines for the diagnosis of asthma in children aged 5–16 years using nine Population, Intervention, Comparator and Outcome (PICO) questions. The task force conducted systematic literature searches for all PICO questions and screened the outputs from these, including relevant full-text articles. All task force members approved the final decision for inclusion of research papers. The task force assessed the quality of the evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.
The task force then developed a diagnostic algorithm based on the critical appraisal of the PICO questions, preferences expressed by lay members and test availability. Proposed cut-offs were determined based on the best available evidence. The task force formulated recommendations using the GRADE Evidence to Decision framework.
Based on the critical appraisal of the evidence and the Evidence to Decision framework, the task force recommends spirometry, bronchodilator reversibility testing and exhaled nitric oxide fraction as first-line diagnostic tests in children under investigation for asthma. The task force recommends against diagnosing asthma in children based on clinical history alone or following a single abnormal objective test. Finally, this guideline also proposes a set of research priorities to improve asthma diagnosis in children in the future.
more
Guidelines for Therapy and Management of Urinary Tract Infection
Guidelines for Therapy and Management of Prostate Cancer in Indonesia
Guidelines for Therapy and Management of Pediatric Urology in Indonesia
Guidelines for Therapy and Management of Acute Coronary Syndrome in Indonesia
Guidelines for Management and Therapy of Atrial Fibrillation in Indonesia